EA200600636A1 - Фармацевтическая композиция для лечения сердечно-сосудистых и цереброваскулярных заболеваний - Google Patents
Фармацевтическая композиция для лечения сердечно-сосудистых и цереброваскулярных заболеванийInfo
- Publication number
- EA200600636A1 EA200600636A1 EA200600636A EA200600636A EA200600636A1 EA 200600636 A1 EA200600636 A1 EA 200600636A1 EA 200600636 A EA200600636 A EA 200600636A EA 200600636 A EA200600636 A EA 200600636A EA 200600636 A1 EA200600636 A1 EA 200600636A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- extract
- cardiovascular
- radix
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Данное изобретение описывает фармацевтическую композицию для лечения сердечно-сосудистых и цереброваскулярных заболеваний, которая содержит экстракт Radix Salviae Miltiorrhizae 5,0-70,0%, экстракт Radix Notoginseng 10,0-85,0%, экстракт Radix Astragali 5,0-70,0% и борнеол или масло Lignum Dalbergiae Odoriferae 1,0-15,0%. Эта композиция является активной против ишемии головного мозга и ишемии миокарда. Эти эффекты превосходят эффекты общих кислот фенольного ряда Radix Salviae Miltiorrhizae или общего сапонина Radix Notoginseng соответственно, или их комбинации. Композиция данного изобретения может обеспечивать препараты разных типов добавлением различных вспомогательных веществ. Таким образом, данное изобретение обеспечивает более эффективную и удобную композицию эффективных ингредиентов Традиционной Китайской Медицины (ТСМ) и ее получение.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031443117A CN100339085C (zh) | 2003-09-23 | 2003-09-23 | 治疗心脑血管疾病的中药组合物 |
PCT/CN2004/001085 WO2005051404A1 (en) | 2003-09-23 | 2004-09-23 | Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200600636A1 true EA200600636A1 (ru) | 2006-08-25 |
EA009730B1 EA009730B1 (ru) | 2008-02-28 |
Family
ID=34624426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600636A EA009730B1 (ru) | 2003-09-23 | 2004-09-23 | Фармацевтическая композиция для лечения сердечно-сосудистых и цереброваскулярных заболеваний |
Country Status (25)
Country | Link |
---|---|
US (1) | US7438935B2 (ru) |
EP (1) | EP1679058B1 (ru) |
JP (1) | JP4943846B2 (ru) |
KR (1) | KR20070028283A (ru) |
CN (1) | CN100339085C (ru) |
AP (1) | AP1908A (ru) |
AT (1) | ATE551100T1 (ru) |
AU (1) | AU2004292351B2 (ru) |
BR (1) | BRPI0414655B8 (ru) |
CA (1) | CA2538478C (ru) |
DK (1) | DK1679058T3 (ru) |
EA (1) | EA009730B1 (ru) |
ES (1) | ES2383599T3 (ru) |
HK (1) | HK1089092A1 (ru) |
LT (1) | LT5433B (ru) |
MY (1) | MY144043A (ru) |
NO (1) | NO334431B1 (ru) |
NZ (1) | NZ546654A (ru) |
PL (1) | PL1679058T3 (ru) |
PT (1) | PT1679058E (ru) |
SA (1) | SA04250309B1 (ru) |
SI (1) | SI1679058T1 (ru) |
UA (1) | UA85065C2 (ru) |
WO (1) | WO2005051404A1 (ru) |
ZA (1) | ZA200603180B (ru) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006115307A1 (en) * | 2005-04-26 | 2006-11-02 | Ko, Boong-Kyung | Method of extracting ginsengnoside rg2m, pharmaceutical composition including ginsengnoside rg2, and uses thereof |
CN1305493C (zh) * | 2005-06-09 | 2007-03-21 | 北京中医药大学 | 一种治疗脑中风的中药有效部位及其分离制备方法 |
EP1905444B1 (en) * | 2005-07-14 | 2014-09-24 | Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd | Preparation method of a medicinal composition containing ginseng secondary glycosides |
CN1919237B (zh) * | 2005-08-24 | 2011-10-05 | 天津天士力制药股份有限公司 | 治疗心脑血管疾病的药物 |
CN1919252B (zh) * | 2005-08-24 | 2011-09-21 | 天津天士力制药股份有限公司 | 一种治疗心脑血管疾病的药物 |
CN1919253B (zh) * | 2005-08-24 | 2010-12-01 | 天津天士力制药股份有限公司 | 一种治疗心脑血管疾病的药物组合物 |
CN1919235B (zh) * | 2005-08-24 | 2010-12-01 | 天津天士力制药股份有限公司 | 治疗心脑血管疾病的药物组合物 |
CN1919238B (zh) * | 2005-08-24 | 2011-10-05 | 天津天士力制药股份有限公司 | 一种治疗心脑血管病的药物 |
CN1919236B (zh) * | 2005-08-24 | 2010-09-29 | 天津天士力制药股份有限公司 | 治疗心脑血管病的药物 |
CN100400047C (zh) * | 2006-04-05 | 2008-07-09 | 黑龙江省珍宝岛制药有限公司 | 一种用于治疗心脑血管疾病的粉针剂及其制备方法和应用 |
CN100563662C (zh) * | 2006-11-28 | 2009-12-02 | 中国科学院上海药物研究所 | 治疗心血管疾病的中药有效成分组合物及其制备方法 |
CN101322801B (zh) | 2007-06-15 | 2011-07-20 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗扩张型心肌病药物中的应用 |
CN101439078B (zh) * | 2007-11-22 | 2012-03-28 | 天津天士力制药股份有限公司 | 一种含黄芪提取物的中药颗粒及其制备方法 |
CN101439079B (zh) * | 2007-11-22 | 2012-04-18 | 天津天士力制药股份有限公司 | 一种含黄芪总皂甙的中药颗粒的制备方法 |
CN101439076B (zh) * | 2007-11-22 | 2012-04-18 | 天津天士力制药股份有限公司 | 一种含降香油的中药颗粒的制备方法 |
CN101524352A (zh) | 2008-03-04 | 2009-09-09 | 江苏先声药物研究有限公司 | 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物 |
US20120041062A1 (en) * | 2009-03-30 | 2012-02-16 | Tianjin Tasly Pharmaceutical Co., Ltd. | Compound of salvianolic acid l, preparation method and use thereof |
CN102028739B (zh) * | 2009-09-29 | 2014-01-29 | 天津天士力现代中药资源有限公司 | 一种治疗冠心病的药物及其制备方法 |
CN102028748A (zh) * | 2009-09-29 | 2011-04-27 | 天津天士力现代中药资源有限公司 | 一种治疗冠心病的药物及提取工艺 |
KR101286870B1 (ko) | 2009-11-30 | 2013-07-16 | (주)아모레퍼시픽 | 황기 추출물을 포함하는 대사 촉진 조성물 |
CN102160872A (zh) * | 2010-02-23 | 2011-08-24 | 天津天士力制药股份有限公司 | 复方丹参滴丸胶囊 |
CN102293820B (zh) | 2010-06-28 | 2015-11-25 | 天士力制药集团股份有限公司 | 一种中药组合物在制备减少心肌梗死后患者死亡事件的药物中的应用 |
US9072745B2 (en) * | 2010-08-06 | 2015-07-07 | Tasly Pharmaceutical Group Co., Ltd | Use of Salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease |
CN102670759A (zh) * | 2012-05-18 | 2012-09-19 | 王显 | 治疗动脉粥样硬化的中药组合物 |
KR20140080289A (ko) | 2012-12-20 | 2014-06-30 | 대전대학교 산학협력단 | 산화적 뇌손상 및 뇌기능 장애의 예방 또는 치료용 조성물 및 이의 제조방법 |
CN103070909B (zh) * | 2013-01-04 | 2015-07-29 | 云南金七制药有限公司 | 三芪软胶囊及其制备方法 |
TWI621443B (zh) | 2013-07-11 | 2018-04-21 | Tasly Pharmaceutical Group Co Ltd | 中藥組合物及其用途、包含該中藥組合物之藥物製劑及複方丹參微滴丸劑、及該微滴丸劑的製備方法 |
MX2015017697A (es) | 2013-07-11 | 2016-08-03 | Talsy Pharmaceutical Group Co Ltd | Composicion de medicina china tradicional, y preparacion y aplicacion de la misma. |
GEP20186901B (en) | 2013-07-11 | 2018-10-10 | Tasly Pharmaceutical Group Co | Micro-drop-pill-shaped compound and preparation method thereof |
CN104418744B (zh) | 2013-08-29 | 2017-03-01 | 天士力制药集团股份有限公司 | 一种新的丹酚酸化合物t、其制备方法和用途 |
CN104013831B (zh) * | 2014-06-05 | 2017-06-23 | 黄艳梅 | 一种治疗脑供血不足的药物 |
CN106632572B (zh) * | 2016-12-16 | 2018-08-14 | 中国科学院成都生物研究所 | 一种黄芪甲苷衍生物及其制备方法和应用 |
KR101892392B1 (ko) | 2017-06-12 | 2018-08-27 | 오형근 | 고혈압 및 당뇨 개선을 위한 조성물 |
CN107582977A (zh) * | 2017-10-18 | 2018-01-16 | 海南梵思科技有限公司 | 一种治疗心血管疾病的中药组合物及其制备方法 |
FR3076458B1 (fr) * | 2018-01-05 | 2022-06-24 | Soc Ind Limousine Dapplication Biologique | Utilisation cosmetique d'extraits de racines de salvia miltiorrhiza, extraits particuliers de racines de salvia miltiorrhiza et compositions cosmetiques incluant de tels extraits |
TW201944990A (zh) * | 2018-04-04 | 2019-12-01 | 大陸商天士力醫藥集團股份有限公司 | 預防和/或治療缺血再灌注損傷的中藥組合物及其製劑和應用 |
CN109394832A (zh) * | 2018-10-29 | 2019-03-01 | 华玉海 | 一种治疗心脑血管病的复方滴丸及其制备方法 |
CN113925892B (zh) * | 2020-06-29 | 2024-04-09 | 天士力医药集团股份有限公司 | 中药芪参益气制剂治疗胃出血的用途 |
CN111991533A (zh) * | 2020-09-11 | 2020-11-27 | 吉林省中医药科学院(吉林省中医药科学院第一临床医院) | 一种治疗冠心病的中药组合物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59303061D1 (de) | 1992-06-29 | 1996-08-01 | Elpatronic Ag | Verfahren zum Zuführen von Dosenzargen zu einer Dosenschweissstation sowie Vorrichtung zu dessen Durchführung |
CN1025774C (zh) * | 1992-11-14 | 1994-08-31 | 连汝安 | 一种特效型山海丹及其生产方法 |
CN1041494C (zh) * | 1993-01-01 | 1999-01-06 | 河南省中药研究所 | 用于治疗慢性缺血性心脏病的一种中药散剂胶囊 |
CN1074613A (zh) * | 1993-01-18 | 1993-07-28 | 邱天道 | 心泰膏 |
CN1085083C (zh) * | 1993-02-17 | 2002-05-22 | 山海丹企业集团西安中医多学科研究所 | 治疗心绞痛型冠心病的药物及生产方法 |
CN1067244C (zh) * | 1996-02-17 | 2001-06-20 | 昆明制药股份有限公司 | 三七皂甙粉针剂 |
CN1242364A (zh) | 1998-07-22 | 2000-01-26 | 中国医科大学 | 治疗消化性溃疡的丹参提取物f及其制备工艺 |
CN1129572C (zh) | 1998-09-11 | 2003-12-03 | 中国科学院上海药物研究所 | 丹参多酚酸盐混合物及其制备方法和用途 |
CN1095363C (zh) * | 1999-05-05 | 2002-12-04 | 方同华 | 精制血塞通注射液的生产工艺 |
CN1274600A (zh) * | 1999-05-24 | 2000-11-29 | 周金龙 | 一种治疗瘫痪的药物及其制备方法 |
CN1095674C (zh) * | 1999-06-18 | 2002-12-11 | 贺云青 | 一种治疗脑血管病及风湿类风湿病的中草药组合物 |
CN1363288A (zh) * | 2001-01-10 | 2002-08-14 | 杨孟君 | 纳米消栓再造制剂药物及其制备方法 |
CN1368061A (zh) * | 2001-01-31 | 2002-09-11 | 杨孟君 | 纳米消栓通络制剂药物及其制备方法 |
WO2002092109A1 (en) * | 2001-05-14 | 2002-11-21 | The Affiliated Hospital Of Chengdu University Of Traditional Chinese Medicine | Herbal composition and its use |
US6589572B2 (en) * | 2001-06-14 | 2003-07-08 | Medvill Co., Ltd. | Hypertension-treatment and cholesterol-depressant composition comprising extract from mixture of Panax notoginseng and Salvia miltiorrhiza and method of preparing the same |
US6616943B2 (en) * | 2001-08-31 | 2003-09-09 | Fountain Silver Limited | Composition comprising Wenguanguo extracts and methods for preparing same |
CN1229324C (zh) * | 2001-09-26 | 2005-11-30 | 中国医学科学院药物研究所 | 丹参总酚酸的提取方法及其制剂的制法与用途 |
TWI275396B (en) * | 2001-10-17 | 2007-03-11 | Braingenesis Biotechnology Co | Composition of traditional Chinese medicines for preventing and treating cerebrovascular disease |
CN1349818A (zh) * | 2001-10-24 | 2002-05-22 | 沈阳药科大学 | 复方丹参有效部位群及其缓释制剂与医药用途和制备方法 |
CN1352985A (zh) | 2001-11-27 | 2002-06-12 | 沈阳药科大学 | 中药丹参有效部位及其缓释制剂与医药用途和制备方法 |
CN1248702C (zh) * | 2002-02-07 | 2006-04-05 | 天津天士力制药股份有限公司 | 治疗冠心病心绞痛的中药制剂及其制备方法 |
CN1202103C (zh) | 2002-05-23 | 2005-05-18 | 天津天士力制药股份有限公司 | 丹参总酚酸的制备方法 |
-
2003
- 2003-09-23 CN CNB031443117A patent/CN100339085C/zh not_active Expired - Lifetime
-
2004
- 2004-09-23 PT PT04762218T patent/PT1679058E/pt unknown
- 2004-09-23 EA EA200600636A patent/EA009730B1/ru not_active IP Right Cessation
- 2004-09-23 AU AU2004292351A patent/AU2004292351B2/en not_active Ceased
- 2004-09-23 MY MYPI20043903A patent/MY144043A/en unknown
- 2004-09-23 NZ NZ546654A patent/NZ546654A/en not_active IP Right Cessation
- 2004-09-23 SI SI200431882T patent/SI1679058T1/sl unknown
- 2004-09-23 UA UAA200603142A patent/UA85065C2/ru unknown
- 2004-09-23 BR BRPI0414655A patent/BRPI0414655B8/pt not_active IP Right Cessation
- 2004-09-23 US US10/572,083 patent/US7438935B2/en active Active
- 2004-09-23 EP EP04762218A patent/EP1679058B1/en active Active
- 2004-09-23 AP AP2006003596A patent/AP1908A/xx active
- 2004-09-23 ES ES04762218T patent/ES2383599T3/es active Active
- 2004-09-23 CA CA2538478A patent/CA2538478C/en not_active Expired - Fee Related
- 2004-09-23 PL PL04762218T patent/PL1679058T3/pl unknown
- 2004-09-23 WO PCT/CN2004/001085 patent/WO2005051404A1/zh active IP Right Grant
- 2004-09-23 AT AT04762218T patent/ATE551100T1/de active
- 2004-09-23 JP JP2006527259A patent/JP4943846B2/ja not_active Expired - Fee Related
- 2004-09-23 KR KR1020067005691A patent/KR20070028283A/ko active Search and Examination
- 2004-09-23 DK DK04762218.8T patent/DK1679058T3/da active
- 2004-09-25 SA SA04250309A patent/SA04250309B1/ar unknown
-
2006
- 2006-04-12 LT LT2006027A patent/LT5433B/lt not_active IP Right Cessation
- 2006-04-20 ZA ZA200603180A patent/ZA200603180B/xx unknown
- 2006-04-21 NO NO20061764A patent/NO334431B1/no not_active IP Right Cessation
- 2006-08-29 HK HK06109600.7A patent/HK1089092A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200600636A1 (ru) | Фармацевтическая композиция для лечения сердечно-сосудистых и цереброваскулярных заболеваний | |
Kelber et al. | Phytotherapy in functional gastrointestinal disorders | |
Petrakou et al. | Ethnopharmacological survey of medicinal plants traded in herbal markets in the Peloponnisos, Greece | |
Park et al. | An anti-inflammatory principle from cactus | |
Wang | Salvia miltiorrhiza: Chemical and pharmacological review of a medicinal plant | |
Ashraf et al. | Effects of Allium sativum (garlic) on systolic and diastolic blood pressure in patients with essential hypertension. | |
Nickavar et al. | Evaluation of the antioxidant capacity and phenolic content of three Thymus species | |
Petkov | Plants with hypotensive, antiatheromatous and coronarodilatating action | |
Joshi et al. | Therapeutic efficiency of Centella asiatica (L.) Urb. An underutilized green leafy vegetable: an overview | |
Benedek et al. | Yarrow (Achillea millefolium L. sl): pharmaceutical quality of commercial samples | |
WO2002058625A3 (en) | Herbal composition for angina pectoris, method to prepare same and uses thereof | |
Kapadia et al. | Inhibitory effect of herbal remedies on 12-O-tetradecanoylphorbol-13-acetate-promoted Epstein–Barr virus early antigen activation | |
Siddiqui et al. | A mini-review of anti-hepatitis B virus activity of medicinal plants | |
Marques et al. | Echinodorus grandiflorus: Ethnobotanical, phytochemical and pharmacological overview of a medicinal plant used in Brazil | |
Arora et al. | A review on phytochemical and pharmacological potential of genus Chelidonium | |
Samoisy et al. | Ethnopharmacological appraisal of culturally important medicinal plants and polyherbal formulas used against communicable diseases in Rodrigues Island | |
Mathew et al. | Phytotherapy in India: transition of tradition to technology. | |
Quassinti et al. | Exploring new applications of tulip tree (Liriodendron tulipifera L.): Leaf essential oil as apoptotic agent for human glioblastoma | |
Belhaj et al. | Medicinal plants used to boost immunity and decrease the intensity of infection caused by SARS-COV-2 in Morocco | |
Yarnell et al. | Accuracy of Dioscorides,'De materia medica (First Century CE), regarding diuretic activity of plants | |
Redouan et al. | Ethnopharmacological preparations used for digestive system disorders in Talassemtane National Park (North of Morocco) | |
EA200600471A1 (ru) | Лечение устойчивости к аспирину с использованием radix salviae multiorrhizae, его экстракта и композиции | |
Haque et al. | Current knowledge regarding pharmacological profile and chemical constituents of Gynura procumbens | |
Rauchensteiner et al. | The Achillea millefolium group (Asteraceae) in Middle Europe and the Balkans: a diverse source for the crude drug Herba Millefolii | |
Negri et al. | Unusual chemical composition of a sample of Brazilian propolis, as assessed by analysis of a chloroform extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ MD TM |
|
TC4A | Change in name of a patent proprietor in a eurasian patent |